When GSDME is activated in tumors, it can transform “cold” tumors that are not recognized by the immune system into “hot” tumors that can be regulated by T cells and tumor-killing cells in the immune system; tumor growth is inhibited and cancer patients benefit from immunotherapy [22]. This evidence concerns the gene GSDME and neoplasm.